Epstein Secrets

cy?" Klobuchar Not Giving Up On Senate Passing Voting Rights Legislation. The Plinneapolic Star Tribune (5/6, 855K) reports that the effort by Sen. Amy Klobuchar (D-MN) to push the For The People Act through the Senate "has all the makings of a moonshot: hard to achieve and fraught with complications." The m

than six months ago." Foreign Health Officials Pause Distribution Of J&J Vaccines Made By Emergent. The New York Times (5/6, Al, Hamby, LaFraniere, Stolberg, 20.6M) reports that "quality-control problems" at Emergent BioSolutions' manufacturing plant in Baltimore, Maryland have led health officials in C

t trails and to boost the ability of election officials to get timely security clearances." Lankford, "who has been working with Minnesota Democrat Amy Klobuchar, told reporters Thursday that with the 2020 primaries and caucuses just around the corner, security enhancements would be meant for the next midter

k (D-MA), "vice chair of the House Democratic Caucus and the highest-ranking Democrat to join the effort." The New York Times (7/25, Fandos, Davis, Stolberg, 18.61M) says "some senior lawmakers" are now "pushing...to begin formal impeachment hearings soon." House Judiciary Chairman Jerrold Nadler "has g

rs in court over allegations of anticompetitive conduct," and "regulators continue to investigate Amazon and Apple over antitrust violations." Sen. Amy Klobuchar (D-MN), who chairs the Senate Commerce Committee's subcommittee on Communications, Technology, Innovation, and the Internet, is quoted as saying, "W

ditional doses. Those people, like several others, spoke on the condition of anonymity to describe internal matters." The New York Times (1/26, Al, Stolberg, Weiland, LaFraniere, 20.6M) says that while Biden "said the moves were `going to allow millions more Americans to get vaccinated sooner than previ

ncy?" Klobuchar Not Giving Up On Senate Passing Voting Rights Legislation. The Minneapolis Star Tribune (5/6, 855K) reports that the effort by Sen. Amy Klobuchar (D-MN) to push the For The People Act through the Senate "has all the makings of a moonshot: hard to achieve and fraught with complications." The m

than six months ago." Foreign Health Officials Pause Distribution Of J&J Vaccines Made By Emergent. The New York Times (5/6, Al, Hamby, LaFraniere, Stolberg, 20.6M) reports that "quality-control problems" at Emergent BioSolutions' manufacturing plant in Baltimore, Maryland have led health officials in C